DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
L-Citrulline is an investigational drug.
There have been 22 clinical trials for L-Citrulline. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Hypertension, Anemia, Sickle Cell, and Syndrome. The leading clinical trial sponsors are Asklepion Pharmaceuticals, LLC, Vanderbilt University, and Vanderbilt University Medical Center.
Recent Clinical Trials for L-Citrulline
|Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes||Duke University||Phase 2|
|Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes||National Heart, Lung, and Blood Institute (NHLBI)||Phase 2|
|Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes||National Institutes of Health (NIH)||Phase 2|